Seyed Mohammad Mahdi Moshirian Farahi

Dr. Seyed Mohammad Mahdi Moshirian Farahi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2022 in Journal of Affective Disorders
Verified
Journal Article
Closed access
JCJude Mary Cénat
Jude Mary Cénat
Seyed Mohammad Mahdi Moshirian FarahiSeyed Mohammad Mahdi Moshirian Farahi
Seyed Mohammad Mahdi Moshirian Farahi
RDRose Darly Dalexis
Rose Darly Dalexis
WDWina Paul Darius
Wina Paul Darius
FBFarid Mansoub Bekarkhanechi
Farid Mansoub Bekarkhanechi
PLPatrick R. Labelle
Patrick R. Labelle

3 October 2022 in Journal of Medical Virology
Verified
Journal Article
Open access
JCJude Mary Cénat
Jude Mary Cénat
PNPari‐Gole Noorishad
Pari‐Gole Noorishad
Seyed Mohammad Mahdi Moshirian FarahiSeyed Mohammad Mahdi Moshirian Farahi
Seyed Mohammad Mahdi Moshirian Farahi
WDWina Paul Darius
Wina Paul Darius
AAAya Mesbahi El Aouame
Aya Mesbahi El Aouame
PLPatrick R. Labelle
Patrick R. Labelle
This systematic review and meta‐analysis examined the prevalence and factors associated with vaccine hesitancy and vaccine unwillingness in Canada. Eleven databases were searched in March 2022. The pooled prevalence of coronavirus disease 2019 (COVID‐19) vaccine hesitancy and unwillingness was estimated. Subgroup analyses and meta‐regressions were performed. Out of 667 studies screened, 86 full‐text articles were reviewed, and 30 were included in the systematic review. Twenty‐four articles were included in the meta‐analysis; 12 for the pooled prevalence of vaccine hesitancy (42.3% [95% CI, 33.7%–51.0%]) and 12 for vaccine unwillingness (20.1% [95% CI, 15.2%−24.9%]). Vaccine hesitancy was higher in females (18.3% [95% CI, 12.4%−24.2%]) than males (13.9% [95% CI, 9.0%−18.8%]), and in rural (16.3% [95% CI, 12.9%−19.7%]) versus urban areas (14.1% [95%CI, 9.9%−18.3%]). Vaccine unwillingness was higher in females (19.9% [95% CI, 11.0%−24.8%]) compared with males (13.6% [95% CI, 8.0%−19.2%]), non‐White individuals (21.7% [95% CI, 16.2%−27.3%]) than White individuals (14.8% [95% CI, 11.0%−18.5%]), and secondary or less (24.2% [95% CI, 18.8%−29.6%]) versus postsecondary education (15.9% [95% CI, 11.6%−20.2%]). Factors related to racial disparities, gender, education level, and age are discussed.

7 October 2022 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
JCJude Mary Cénat
Jude Mary Cénat
LKLesly Nzeusseu Kouamou
Lesly Nzeusseu Kouamou
Seyed Mohammad Mahdi Moshirian FarahiSeyed Mohammad Mahdi Moshirian Farahi
Seyed Mohammad Mahdi Moshirian Farahi
WDWina Paul Darius
Wina Paul Darius
RDRose Darly Dalexis
Rose Darly Dalexis
CKCary S. Kogan
Cary S. Kogan

24 April 2023 in Journal of Medical Virology
Verified
Journal Article
Open access
JCJude Mary Cénat
Jude Mary Cénat
Seyed Mohammad Mahdi Moshirian FarahiSeyed Mohammad Mahdi Moshirian Farahi
Seyed Mohammad Mahdi Moshirian Farahi
SBSchwab Mulopo Bakombo
Schwab Mulopo Bakombo
RDRose Darly Dalexis
Rose Darly Dalexis
RPRoland Pongou
Roland Pongou
VVVivek Venkatesh
Vivek Venkatesh
The COVID‐19 pandemic disproportionately affected Black communities in Canada in terms of infection and mortality rates compared to the general population. Despite these facts, Black communities are among those with the highest level of COVID‐19 vaccine mistrust (COVID‐19 VM). We collected novel data to analyze the sociodemographic characteristics and factors associated with COVID‐19 VM among Black communities in Canada. A survey was conducted among a representative sample of 2002 Black individuals (51.66% women) aged 14−94 years (M = 29.34; SD = 10.13) across Canada. Vaccine mistrust was assessed as the dependent variable and conspiracy theories, health literacy, major racial discrimination in healthcare settings, and sociodemographic characteristics of participants were assessed as independent variables. Those with a history of COVID‐19 infection had higher COVID‐19 VM score (M = 11.92, SD = 3.88) compared to those with no history of infection (M = 11.25, SD = 3.83), t (1999) = −3.85, p < 0.001. Participants who reported having experienced major racial discrimination in healthcare settings were more likely to report COVID‐19 VM (M = 11.92, SD = 4.03) than those who were not (M = 11.36, SD = 3.77), t (1999) = −3.05, p = 0.002. Results also showed significant differences for age, education level, income, marital status, provinces, language, employment status, and religion. The final hierarchical linear regression showed that conspiracy beliefs (B = 0.69, p < 0.001) were positively associated with COVID‐19 VM, while health literacy (B = −0.05, p = 0.002) was negatively associated with it. The mediated moderation model showed that conspiracy theories completely mediated the association between racial discrimination and vaccine mistrust (B = 1.71, p < 0.001). This association was also completely moderated by the interaction between racial discrimination and health literacy (B = 0.42, p = 0.008), indicating that despite having a high level of health literacy, those who experienced major racial discrimination in health services developed vaccine mistrust. This first study on COVID‐19 VM exclusively among Black individuals in Canada provides data that can significantly impact the development of tools, trainings, strategies, and programs to make the health systems free of racism and increase their confidence in vaccination for COVID‐19 and other infectious diseases.

12 July 2023 in Psychiatry Research
Verified
Journal Article
Open access
JCJude Mary Cénat
Jude Mary Cénat
Seyed Mohammad Mahdi Moshirian FarahiSeyed Mohammad Mahdi Moshirian Farahi
Seyed Mohammad Mahdi Moshirian Farahi
RDRose Darly Dalexis
Rose Darly Dalexis
The COVID-19 pandemic has disproportionately affected Black communities in Canada in terms of infection, hospitalizations, and mortality rates. It exacerbated social, economic, and health disparities that can impact their mental health. We investigated the prevalence and predictors of symptoms of depression, anxiety, and stress in Black individuals in Canada. A community-representative weighted sample of 2002 Black individuals (51.66% women) aged 14 to 94 years old (Mean age 29.34; SD = 10.13). Overall, 40.94%, 44.50%, and 31.36% of participants were classified as having clinically meaningful anxiety, depression, and stress levels, respectively, based on DASS scores. Men (45.92%) reported a higher prevalence of anxiety than women (36.27%), χ2 (1) = 19.24, p<.001, but similar symptoms of depression and stress. The progression of the prevalence of anxiety, depression, and stress symptoms were consistent with the progression of the prevalence of everyday racial discrimination. After controlling for socio-demographic variables, regression models showed that everyday discrimination (B = 0.14, p=.001, B = 0.14, p= .006, B = 0.18, p< .001), major experiences of racial discrimination (B = 0.30, p=.046, B = 0.34, p= .033, B = 0.35, p=.024), and COVID-19 traumatic stressors (B = 0.43, p<.001, B = 0.43, p< .001, B = 0.44, p< .001) were positively associated with anxiety, while community resilience (B= -0.02, p= .039, B= -0.04, p= .001, B= -0.03, p= .014) was negatively associated with anxiety, depression, and stress, respectively. This study demonstrates the need to address racial discrimination in implementing prevention and intervention programs among Black individuals and to consider intersectional factors related to age, birthplace, language spoken, and province of residence.

25 October 2023 in Vaccine
Verified
Journal Article
Open access
JCJude Mary Cénat
Jude Mary Cénat
Seyed Mohammad Mahdi Moshirian FarahiSeyed Mohammad Mahdi Moshirian Farahi
Seyed Mohammad Mahdi Moshirian Farahi
CBCathy Broussard
Cathy Broussard
RDRose Darly Dalexis
Rose Darly Dalexis
Black communities in Canada have been among the most affected by the COVID-19 pandemic, in terms of number of infections and deaths. They are also among those most hesitant about vaccination against COVID-19. However, while a few studies have documented the factors associated with COVID-19 vaccine hesitancy, those related to vaccine confidence remain unknown. To respond to this gap, this study aims to investigate factors associated to vaccine confidence in Black individuals in Canada. A total of 2002 participants (1034 women) aged 14 to 89 years old (Mean age = 29.34, SD = 10.13) completed questionnaires assessing sociodemographic information, COVID-19 vaccine confidence and need, health literacy, conspiracy beliefs, major racial discrimination, and traumatic stressors related to COVID-19. Results showed an average score of COVID-19 vaccine confidence and need of 33.27 (SD = 7.24), with no significant difference between men (33.48; SD = 7.24) and women (33.08; SD = 7.91), t (1999) = 1.19, p = 0.234. However, there were significant differences according to employment status, migration status, age, inhabited province, spoken language, education, marital status, religion, and income. The linear regression model explained 25.8 % of the variance and showed that health literacy (B = 0.12, p < 0.001) and traumatic stressors related to COVID-19 (B = 0.21, p < .001) predicted COVID-19 vaccine confidence and need positively, while conspiracy beliefs (B = -1.14, p < 0.001) and major racial discrimination (B = -0.20, p = 0.044) predicted it negatively. This study showed that building the confidence of Black communities in vaccines requires health education, elimination of racial discrimination in the Canadian society and a focus on certain groups (e.g., young people, those living in Quebec and Ontario). The results also argue in favor of involving community leaders and organizations in the development and implementation of vaccination-related tools, strategies and programs by city, provincial and federal public health agencies.